Only export! Paraquat officially withdrew from the domestic market
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-07
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Polyvantis Opens Shanghai Technical Center
-
Axplora Expands Indian Market: €6.5 Million to Expand API Manufacturing in Vizag
-
Saint-Gobain Makes Construction Chemicals Acquisitions in Canada, Italy, and Peru
-
Huide Technology Partners with U.S. Firm to Open the Door to Mass Production of Circular TPU
-
Kemira to Expand Drinking Water Treatment Portfolio with New ACH Production Line
-
Sinopec Builds 146 Hydrogen Refueling Stations, Ranking Among the World’s Largest Operators
-
Sika Impacted by Weaker Dollar in H1, Lowers Full-Year Sales Guidance
-
The World's First Thousand-Ton Ionic Liquid Regenerated Fiber Project Is POut Into Production in Henan
-
Wacker Invests 300 Million Euros in New Semiconductor-Grade Polysilicon Production Line in Germany
-
SIBUR Develops New Polypropylene for Retort Packaging
Recommend Reading
-
TDI Supply Tightens and Prices Surge: Can Cangzhou Dahua Reap the "Chemical Dividend"?
-
Bodo Möller Chemie to Acquire Adhesive Chemicals Business of Aqua Engineering Services
-
Azelis Acquires Italian Specialty Chemicals Distributor ACEF
-
TotalEnergies Sells 50% Stake in 604 MW Renewable Energy Portfolio in Portugal
-
Avril Group to Acquire Champlor Renewables from Valtris
-
Coking Coal Market Prices Remain Stable, with Little Price Fluctuation
-
Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330
-
The Game Between Costs and Demand: Melamine Remains Stable
-
Supply-Demand Gap Widens, Lithium Carbonate Prices Approach Year-to-Date High
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough